The Nation - News from Dec. 11, 1987
- Share via
Armour Pharmaceutical is recalling 208 lots of a blood clotting agent distributed for hemophilia patients because of the possibility it could contain the AIDS virus, the Food and Drug Administration said. The FDA announcement said the Bluebell, Pa., firm estimates that 2,000 to 5,000 doses of the clotting agent called H. T. Factorate are on the market in the United States. Six patients in Canada who were taking doses from lots processed using the same heat treatment have tested positive for the AIDS virus.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
